Articles with Puma Biotechnology
News Release
Why Puma Biotechnology Shares Dropped 17.7% This Week | The Motley Fool
Puma Biotechnology (PBYI) Stock Climbs On Orphan Drug Designation | Alpha Stock News
PBYI | Puma Biotechnology Inc. Stock Overview (U.S.: Nasdaq) | Barron's
Is Puma Biotechnology (PBYI) Stock a Solid Choice Right Now?
Puma Biotechnology (PBYI) Q1 Earnings: Stock To Disappoint? | Investing.com
PUMA BIOTECHNOLOGY, INC. : PBYI Stock Price | US74587V1070 | MarketScreener
Why Puma Biotech Could Get Acquired Between July to September of This Year | BioSpace
With 53% institutional ownership, Puma Biotechnology, Inc. (NASDAQ:PBYI) is a favorite amongst the big guns | Nasdaq
Puma Biotech In-Licenses Takeda's Cancer Candidate With Primary Focus On Breast & Lung Cancer
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News
Video Puma Biotechnology Soars on Breast Cancer Drug Results - ABC News
Puma Biotechnology Inc
Puma Biotechnology Inc (PBYI) Stock: Do Analysts Think You Should Sell?
Puma Biotechnology falls more than 20%
PBYI Institutional Ownership and Shareholders - Puma Biotechnology Inc (NASDAQ) Stock
Puma Biotechnology Inc. (PBYI) Stock Price, Quote & News - Stock Analysis
Stocks to Watch: Dropbox, Nike, Tronc, Qualcomm, Puma Biotechnology, Invitation Homes, Universal Display - WSJ
Why Puma Biotechnology, Inc. Stock Crashed 37% in March | The Motley Fool
Puma Biotechnology Inc (PBYI) Stock: Do Analysts Think You Should Sell?
Why Puma Biotechnology Is Soaring Today | The Motley Fool
